
Can-Fite BioPharma Ltd. CANF
€ 2.49
-0.34%
Geschäftsbericht 2025
hinzugefügt 25.04.2026
Can-Fite BioPharma Ltd. DSO 2011-2026 | CANF
DSO Jährlich Can-Fite BioPharma Ltd.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 28.1 | 46.9 | 1.37 K | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.37 K | 28.1 | 482 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 21.81 | 1.87 % | $ 1.02 B | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
20.6 | $ 0.91 | 1.61 % | $ 6.69 M | ||
|
ACADIA Pharmaceuticals
ACAD
|
37.5 | $ 22.56 | 2.73 % | $ 3.74 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 1.97 | 3.14 % | $ 409 M | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Heron Therapeutics
HRTX
|
198 | $ 1.21 | 1.26 % | $ 202 M | ||
|
ImmuCell Corporation
ICCC
|
47.5 | $ 8.22 | -1.56 % | $ 74.2 M | ||
|
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | ||
|
Jaguar Health
JAGX
|
48.3 | $ 0.34 | -13.72 % | $ 793 K | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | ||
|
KalVista Pharmaceuticals
KALV
|
9.64 | $ 19.68 | 0.25 % | $ 1.06 B | ||
|
Aquestive Therapeutics
AQST
|
103 | $ 4.12 | 0.86 % | $ 441 M | ||
|
Arcutis Biotherapeutics
ARQT
|
106 | $ 23.45 | 0.82 % | $ 2.98 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
58.2 | $ 1.44 | -0.35 % | $ 383 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
77.8 | $ 232.91 | 0.71 % | $ 4.26 B | ||
|
Eli Lilly and Company
LLY
|
80.5 | $ 880.24 | -0.42 % | $ 790 B | ||
|
BioDelivery Sciences International
BDSI
|
115 | - | -4.8 % | $ 255 M |